Stock futures are slipping after China’s third-quarter economic growth came in below economists’ forecasts. Here’s what we’re watching ahead of Monday’s opening bell.
-
dropped 6.7% premarket. The online real-estate company told Bloomberg that it won’t purchase homes for the rest of the year, saying that it was “beyond operational capacity.”
-
and
are due to report earnings before the open.
- Crude prices were climbing early Monday, boosting the share prices of producers.
gained 1% and
added 0.9%.
- Bitcoin was trading above $61,000, and digital-wallet provider
was up more than 1% before the bell.
- U.S.-traded shares of French biotech
soared 41% premarket. It said its coronavirus vaccine candidate outperformed
‘s in a Phase 3 study, which met both its co-primary endpoints.
-
meanwhile, was flat after a panel of outside doctors and experts voted 19-0 to recommend that all adults who received a first dose of the Johnson & Johnson vaccine should get the second dose at least two months later.
- Vaccine maker
was down 1.4% premarket. Last week the FDA delayed a decision on making its Covid-19 shot available for adolescents, to assess whether it may lead to heightened risk of a rare inflammatory heart condition.
-
will report earnings after the close.
Chart of the Day
- Hong Kong started trading in futures tied to an index of stocks from mainland China, giving global investors a new tool for betting on Chinese markets.
Write to James Willhite at james.willhite@wsj.com
Copyright ©2021 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8